Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
+$656M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$612M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$353M |
| 5 |
Walmart
WMT
|
+$316M |
Top Sells
| 1 |
Apple
AAPL
|
+$483M |
| 2 |
PepsiCo
PEP
|
+$394M |
| 3 |
RHT
Red Hat Inc
RHT
|
+$248M |
| 4 |
Philip Morris
PM
|
+$246M |
| 5 |
Eli Lilly
LLY
|
+$240M |
Sector Composition
| 1 | Healthcare | 18.91% |
| 2 | Technology | 12.35% |
| 3 | Consumer Discretionary | 10.31% |
| 4 | Financials | 9.99% |
| 5 | Consumer Staples | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Hain Celestial
HAIN
$194M
| $3.08M | ﹤0.01% |
143,222
+131,100
| +1,082% | +$2.82M |
|
|
PRCP
2052
DELISTED
Perceptron Inc
PRCP
| $3.06M | ﹤0.01% |
637,935
+24,805
| +4% | +$119K |
|
2053
Vermilion Energy
VET
$1.14B
| $3.04M | ﹤0.01% |
182,042
+82,442
| +83% | +$1.38M |
|
2054
LKQ Corp
LKQ
$8.31B
| $3.03M | ﹤0.01% |
96,386
-74,974
| -44% | -$2.36M |
|
2055
Mesa Air Group
MESA
$57.4M
| $3.03M | ﹤0.01% |
449,207
+20,907
| +5% | +$141K |
|
2056
Townsquare Media
TSQ
$115M
| $3.03M | ﹤0.01% |
430,745
+5,708
| +1% | +$40.1K |
|
2057
Akamai
AKAM
$11B
| $3.03M | ﹤0.01% |
33,100
-685,500
| -95% | -$62.6M |
|
2058
Alpha Metallurgical Resources
AMR
$1.87B
| $3.02M | ﹤0.01% |
108,100
+59,200
| +121% | +$1.65M |
|
2059
Great Elm Group
GEG
$82.6M
| $3.02M | ﹤0.01% |
821,704
+12,949
| +2% | +$47.5K |
|
2060
Ryder
R
$7.65B
| $3.01M | ﹤0.01% |
58,200
-2,200
| -4% | -$114K |
|
2061
Amcor
AMCR
$19.1B
| $2.99M | ﹤0.01% |
311,065
-683,597
| -69% | -$6.58M |
|
2062
Miller Industries
MLR
$455M
| $2.99M | ﹤0.01% |
89,700
-38,200
| -30% | -$1.27M |
|
|
GCP
2063
DELISTED
GCP Applied Technologies Inc.
GCP
| $2.98M | ﹤0.01% |
155,000
-166,400
| -52% | -$3.2M |
|
|
FMBI
2064
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $2.98M | ﹤0.01% |
152,771
-33,000
| -18% | -$643K |
|
|
SYRS
2065
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $2.98M | ﹤0.01% |
28,660
-1,080
| -4% | -$112K |
|
|
VRTV
2066
DELISTED
VERITIV CORPORATION
VRTV
| $2.94M | ﹤0.01% |
162,400
+69,000
| +74% | +$1.25M |
|
|
AIU
2067
DELISTED
Meta Data Limited American Depositary Shares, each representing ten (10) Class A Ordinary Shares
AIU
| $2.93M | ﹤0.01% |
3,176
+543
| +21% | +$502K |
|
2068
Resources Connection
RGP
$172M
| $2.93M | ﹤0.01% |
172,542
+82,072
| +91% | +$1.39M |
|
|
YELL
2069
DELISTED
Yellow Corporation Common Stock
YELL
| $2.92M | ﹤0.01% |
966,253
+141,267
| +17% | +$427K |
|
2070
Clear Channel Outdoor Holdings
CCO
$651M
| $2.92M | ﹤0.01% |
1,157,049
-916,100
| -44% | -$2.31M |
|
2071
ICF International
ICFI
$1.83B
| $2.91M | ﹤0.01% |
34,500
-12,613
| -27% | -$1.07M |
|
2072
argenx
ARGX
$46.3B
| $2.91M | ﹤0.01% |
25,500
-56,900
| -69% | -$6.48M |
|
2073
Alico
ALCO
$260M
| $2.91M | ﹤0.01% |
85,424
+14,717
| +21% | +$501K |
|
|
KDNY
2074
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $2.9M | ﹤0.01% |
547,640
+185,200
| +51% | +$981K |
|
2075
ORIX
IX
$30B
| $2.9M | ﹤0.01% |
193,000
+86,160
| +81% | +$1.3M |
|